| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/05/2004 | WO2004064757A2 Absorption enhancing agents |
| 08/05/2004 | WO2004064731A2 Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues |
| 08/05/2004 | WO2004064719A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 08/05/2004 | WO2004064595A2 Multivalent constructs for therapeutic and diagnostic applications |
| 08/05/2004 | WO2004064539A2 Fat substitutes |
| 08/05/2004 | WO2004054557A3 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 08/05/2004 | WO2004045494A9 Biological glue based on thrombin-conjugated nanoparticles |
| 08/05/2004 | WO2004043389A3 Methods of treating cancer and related methods |
| 08/05/2004 | WO2004043146A3 Composition and method for mammary disinfection during winter conditions |
| 08/05/2004 | WO2004041307A3 Compositions and methods for treating cancer using cytotoxic cd44 antibody immunoconjugates and radiotherapy |
| 08/05/2004 | WO2004033645A3 Methods of regulating body weight |
| 08/05/2004 | WO2004032859A3 Water soluble sheet composition |
| 08/05/2004 | WO2004012680B1 Lipid-drug complexes in reversed liquid and liquid crystalline phases |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2004001019A3 Novel nanoparticles and use thereof |
| 08/05/2004 | WO2004000226A3 Liposomes containing biologically active compounds |
| 08/05/2004 | WO2003102150A3 Multi-functional polyamines for delivery of biologically-active polynucleotides |
| 08/05/2004 | WO2003072058A3 Dna-binding polyamide drug conjugates |
| 08/05/2004 | WO2003068144A3 Cytotoxic agents |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | US20040152777 Therapeutically active compounds |
| 08/05/2004 | US20040152769 Anticancer, antitumor agents; viricides; antiarthritic agents |
| 08/05/2004 | US20040152752 Administering cyclooxygenase inhibitor; topical administering |
| 08/05/2004 | US20040152682 Stabilized steroid composition and method for its preparation |
| 08/05/2004 | US20040152664 Prednisolone compositions |
| 08/05/2004 | US20040152663 Dissolving an amphiphilic heparin derivative comprising heparin covalently bonded to a hydrophobic agent selected from bile acids, sterols, alkanoic acids, and mixtures thereof in a water phase; dispersing in organic phase; drying emulsion |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152632 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome |
| 08/05/2004 | US20040152181 In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152071 Complex of transferrins or transcobalamin with viricides; prevention reproduction of virus |
| 08/05/2004 | US20040152042 Dispensing apparatus and cartridge with deformable tip |
| 08/05/2004 | US20040151855 Injection-molded water soluble container |
| 08/05/2004 | US20040151793 Onion extract can be integrated into base containing oil without effectiveness being reduced or phase separation being produced |
| 08/05/2004 | US20040151781 Osteoporosis, hormone-related disorders |
| 08/05/2004 | US20040151779 suspending an active agent-containing powder with active agent hydration less than about 10% in at least one anhydrous, aprotic, hydrophobic, non-polar, low-reactivity vehicle; useful to delivery to an animal for sustained release for long term treatment |
| 08/05/2004 | US20040151778 Plant protein-based microcapsules |
| 08/05/2004 | US20040151777 Modified cellulose films |
| 08/05/2004 | US20040151776 Novel compositions |
| 08/05/2004 | US20040151775 Membrane active polymers |
| 08/05/2004 | US20040151773 core containing a complex of the benzimidazole derivative e.g., omeprazole, lansoprazole, pantoprazole, or timoprazole, and ion-exchange resin, and the enteric coating agent having the degree of substitution by an acidic group of less than 30%, |
| 08/05/2004 | US20040151763 pH adjuster namely citric acid, preservative, and an anti-irritant agent, especially a local anesthetic, analgesic, anesthetic, antipruitic, astringent, hydrocortisone preparation, or keratolytic; feminine wipe |
| 08/05/2004 | US20040151758 fatty acids whose yield energy from beta-oxidation is sufficiently low so that the compound is rendered metabolically low caloric or non-caloric, or a physiologically acceptable ester thereof or a metabolic precursor thereof |
| 08/05/2004 | US20040151756 Edible low density high surface area drug vehicle, method of manufacturing low density high surface area drug vehicle |
| 08/05/2004 | US20040151753 biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent; sustained release |
| 08/05/2004 | US20040151752 Hydrogel entrapping therapeutic agent and stent with coating comprising this |
| 08/05/2004 | US20040151743 Antibacterial composition for topical administration containing antibiotic |
| 08/05/2004 | US20040151741 containing a sequestration agent including proteins, lipids and carbohydrates, particularly albumin; treating neuromuscular diseases and pain |
| 08/05/2004 | US20040151739 transporter and fusion protein contains a binding domain for the transporter and a modulation domain for the covalent modification of small GTP-binding proteins; transporter permits the uptake of the fusion protein in a target cell |
| 08/05/2004 | US20040151710 Topical composition for treating infectious conditions of skin and mucosa |
| 08/05/2004 | US20040151703 Composition for treatment of articular cartilage damage |
| 08/05/2004 | US20040151690 Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 08/05/2004 | US20040151687 Poly(diallylamine)-based bile acid sequestrants |
| 08/05/2004 | DE20220910U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids |
| 08/05/2004 | CA2798615A1 Novel cocrystallization of hydrochloric acid salt of an active agent |
| 08/05/2004 | CA2553313A1 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/05/2004 | CA2514325A1 A composition material for transmucosal delivery |
| 08/05/2004 | CA2514130A1 Therapeutically active compounds |
| 08/05/2004 | CA2514126A1 Fat substitutes |
| 08/05/2004 | CA2513331A1 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513320A1 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | CA2513004A1 Aptamer therapeutics useful in ocular pharmacotherapy |
| 08/05/2004 | CA2512824A1 Improved oral delivery of peptides |
| 08/05/2004 | CA2512780A1 Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 08/05/2004 | CA2512144A1 Solid surface for biomolecule delivery and high-throughput assay |
| 08/05/2004 | CA2488677A1 Method of inhibiting prostate cancer cell proliferation |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1442753A1 Composition for the prevention of indwelling device related infection |
| 08/04/2004 | EP1442751A1 Method of imaging |
| 08/04/2004 | EP1442747A1 Superoxide dismutase and mimetics thereof |
| 08/04/2004 | EP1442746A1 Stable solid formulation of enalapril salt and process for preparation thereof |
| 08/04/2004 | EP1442745A1 Orally administrable opioid formulations having extended duration of effect |
| 08/04/2004 | EP1442066A1 Compositions comprising chitosan in the form of nano-sized fibres |
| 08/04/2004 | EP1442004A1 Alkyl(en)ylglycerinether carboxylic acids |
| 08/04/2004 | EP1441785A2 Improved method for generating an aerosol |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441771A1 Aqueous sustained-release formulations of proteins |
| 08/04/2004 | EP1441770A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility |
| 08/04/2004 | EP1441769A1 Low concentration of peroxide for treating or preventing vaginal infections |
| 08/04/2004 | EP1441768A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use |
| 08/04/2004 | EP1441767A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
| 08/04/2004 | EP1441766A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 08/04/2004 | EP1441765A2 Method for preparation of single chain antibodies |
| 08/04/2004 | EP1441764A2 Antigen arrays comprising rankl for treatment of bone disease |
| 08/04/2004 | EP1441763A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid |
| 08/04/2004 | EP1441755A2 Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases |
| 08/04/2004 | EP1441748A2 High-concentration protein formulations and method of manufacture |
| 08/04/2004 | EP1441727A1 Depot formulations of iloperidone and a star polymer |
| 08/04/2004 | EP1441713A1 Modified release tamsulosin tablets |
| 08/04/2004 | EP1441705A1 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs |
| 08/04/2004 | EP1441704A1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 08/04/2004 | EP1441703A2 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441700A1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/04/2004 | EP1441698A1 Flashmelt oral dosage formulation |
| 08/04/2004 | EP1441696A1 Method and composition for dry eye treatment |